Brief: Encompass Health Q2 Adjusted EPS USD 0.95 Vs. IBES Estimate USD 0.75
01/08/2023 21:30
Aug 01 (Reuters) - Encompass Health Q2 adjusted free cash flow USD 124.2 million. * Q2 adjusted EBITDA USD 249.6 million * Q2 operating revenue USD 1,187.1 million
Recent news on Encompass Health
See all newsBrief: Encompass Health Issues Notice For Partial Redemption Of Its 4.500% Senior Notes Due 2028
Brief: Encompass Health Announces Pricing Of $500 Million Of Senior Notes Due 2034 In A Private Offering
Brief: Encompass Health Announces Private Offering Of Senior Notes
Brief: Encompass Health Announces Plans To Build A 50-Bed Inpatient Rehabilitation Hospital In Post Falls, Idaho
Brief: Encompass Health Declares Dividend On Common Stock